Price of bevacizumab for intravitreal injection in New Zealand.
Abeysiri
Poorna
P
Johnston
Nicholas R
NR
Molteno
Anthony C B
AC
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000191:economics*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000191:economics*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D017046:Cost Savings / Q000379:methods; D003365:Costs and Cost Analysis; D016527:Drug Costs; D006801:Humans; D007267:Injections; D009520:New Zealand; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab